ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2002, 'Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan', Gastroenterology, 123, pp. 92 - 105, http://dx.doi.org/10.1053/gast.2002.34156
,2001, 'Helicobacter pylori infection and gastric cancer', Current Opinion in Gastroenterology, 17
,2001, 'The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer', Nature, 412, pp. 99, http://dx.doi.org/10.1038/35083631
,2001, 'The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer.', Nature, 412, pp. 99
,2001, 'The importance of interleukin 1 β in Helicobacter pylori associated disease', Gut, 48, pp. 743 - 747, http://dx.doi.org/10.1136/gut.48.6.743
,2001, 'Non-invasive HP testing versus endoscopy with HP testing for dyspepsia', GUT, 48, pp. A14 - A15, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000167334700053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2001, 'Cytokine gene polymorphisms and risk of gastric cancer', Japanese Journal of Gastroenterology, 98, pp. A303 - A305, http://dx.doi.org/10.11405/nisshoshi1964.98.87sokai_A303
,2001, 'Gastric cancer and H. pylori: Host genetics open the way', Gastroenterology, 121, pp. 1002 - 1004, http://dx.doi.org/10.1053/gast.2001.28739
,2001, 'IL-1beta and IL-10 genotypes in a high gastric cancer risk province in China', Gastroenterology, 120, pp. A743 - A743, http://dx.doi.org/10.1016/s0016-5085(08)83701-8
,2001, 'Non-invasive H. pylori testing versus endoscopy with H. pylori testing for dyspepsia', Gastroenterology, 120, pp. A238 - A238, http://dx.doi.org/10.1016/s0016-5085(08)81180-8
,2001, 'Pro-inflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomas', Gastroenterology, 120, pp. A86 - A86, http://dx.doi.org/10.1016/s0016-5085(08)80425-8
,2000, 'When enthusiasm is infectious - Reply', GASTROENTEROLOGY, 119, pp. 276 - 276, http://dx.doi.org/10.1016/S0016-5085(00)70071-0
,2000, 'Interleukin-1 polymorphisms associated with increased risk of gastric cancer', Nature, 404, pp. 398 - 402, http://dx.doi.org/10.1038/35006081
,2000, 'Helicobacter pylori gastritis and gastric physiology', Gastroenterology Clinics of North America, 29, pp. 687 - 703, http://dx.doi.org/10.1016/S0889-8553(05)70138-2
,2000, 'Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H-pylori', GASTROENTEROLOGY, 118, pp. 22 - 30, http://dx.doi.org/10.1016/S0016-5085(00)70410-0
,2000, 'Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: Impact of gastroesophageal reflux disease', American Journal of Gastroenterology, 95, pp. 101 - 105, http://dx.doi.org/10.1016/S0002-9270(99)00765-0
,2000, 'The role of gastrin in ulcer pathogenesis', Bailliere's Best Practice and Research in Clinical Gastroenterology, 14, pp. 13 - 26, http://dx.doi.org/10.1053/bega.1999.0056
,2000, 'When enthusiasm is infectious [1] (multiple letters)', Gastroenterology, 119, pp. 274 - 276, http://dx.doi.org/10.1053/gast.2000.9116
,2000, 'Interleukin-10 promoter polymorphisms influence risk of chronic H. pylori infection', Gastroenterology, 118, pp. A889 - A889, http://dx.doi.org/10.1016/s0016-5085(00)85694-2
,2000, 'Interleukin-1B-enhancing genotypes are associated with increased risk of gastric cancer and its precursors', Gastroenterology, 118, pp. A181 - A181, http://dx.doi.org/10.1016/s0016-5085(00)82800-0
,1999, 'Helicobacter pylori and nonulcer dyspepsia [1] (multiple letters)', New England Journal of Medicine, 340, pp. 1508 - 1511, http://dx.doi.org/10.1056/NEJM199905133401912
,1999, 'Dyspepsia on withdrawal of ranitidine in previously asymptomatic volunteers', American Journal of Gastroenterology, 94, pp. 1209 - 1213, http://dx.doi.org/10.1016/S0002-9270(99)00124-0
,1999, 'Symptomatic benefit 1-3 years post H-pylori eradication in ulcer patients: Impact of reflux disease', GUT, 44, pp. A120 - A120, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000079446300478&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'Reply', Gastroenterology, 117, pp. 271 - 272, http://dx.doi.org/10.1016/s0016-5085(99)70580-9
,1998, 'Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia', New England Journal of Medicine, 339, pp. 1869 - 1874, http://dx.doi.org/10.1056/NEJM199812243392601
,1998, 'Effect of antral atrophy on gastric function in h. pylori infection: Relevance to progression to pangastritis', Zeitschrift fur Gastroenterologie, 36, pp. 1090
,1998, 'Prevalence of atrophy and hypochlorhydria is high in gastric cancer relatives and related to H-pylori status.', GASTROENTEROLOGY, 114, pp. A590 - A590, http://dx.doi.org/10.1016/S0016-5085(98)82402-5
,1998, 'UK MRC trial of H-pylori eradication therapy for non-ulcer ulcer dyspepsia.', GASTROENTEROLOGY, 114, pp. A222 - A222, http://dx.doi.org/10.1016/S0016-5085(98)80900-1
,1998, 'H-pylori-associated hypochlorhydria - Reply', GASTROENTEROLOGY, 114, pp. 620 - 621, http://dx.doi.org/10.1016/S0016-5085(98)70559-1
,1998, 'Prevalence of atrophy and hypochlorhydria is high in gastric cancer relatives and related to H-pylori status.', GUT, 42, pp. A51 - A51, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072567900205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1998, 'UK MRC trial of H-pylori eradication therapy for non-ucler dyspepsia', GUT, 42, pp. A3 - A3, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072567900011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1998, 'Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer', Gut, 42, pp. 618 - 622, http://dx.doi.org/10.1136/gut.42.5.618
,1998, 'H. pylori-associated hypochlorhydria [2] (multiple letters)', Gastroenterology, 114, pp. 618 - 620, http://dx.doi.org/10.1016/s0016-5085(98)70558-x
,1998, 'Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy', British Medical Bulletin, 54, pp. 121 - 138, http://dx.doi.org/10.1093/oxfordjournals.bmb.a011663
,1998, 'The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects', Gastroenterology, 114, pp. 50 - 57, http://dx.doi.org/10.1016/S0016-5085(98)70632-8
,1998, 'Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer', European Journal of Gastroenterology & Hepatology, 10, pp. 626 - 626, http://dx.doi.org/10.1097/00042737-199807000-00025
,1997, 'Alterations in gastric physiology in Helicobacter pylori infection: Causes of different diseases or all epiphenomena?', Italian Journal of Gastroenterology and Hepatology, 29, pp. 459 - 464
,1997, 'The role of Helicobacter pylori in the pathophysiology of duodenal ulcer disease and gastric cancer', Seminars in Gastrointestinal Disease, 8, pp. 142 - 155
,1997, 'The role of H. Pylori infection in the pathophysiology of duodenal ulcer disease', Journal of Physiology and Pharmacology, 48, pp. 287 - 295
,1997, 'Helicobacter pylori infection and chronic gastric acid hyposecretion', Gastroenterology, 113, pp. 15 - 24, http://dx.doi.org/10.1016/S0016-5085(97)70075-1
,1997, 'The Glasgow Dyspepsia Severity Score - A tool for the global measurement of dyspepsia (multiple letters) [1]', European Journal of Gastroenterology and Hepatology, 9, pp. 413 - 414, http://dx.doi.org/10.1097/00042737-199704000-00018
,1997, 'The Helicobacter pylori breath test: A surrogate marker for peptic ulcer disease in dyspeptic patients', Gut, 40, pp. 302 - 306, http://dx.doi.org/10.1136/gut.40.3.302
,1996, 'Marked rebound acid hypersecretion after treatment with ranitidine', American Journal of Gastroenterology, 91, pp. 355 - 359
,1996, 'Gastrin-releasing peptide, acid secretion, Helicobacter pylori, and duodenal ulcer: Another epiphenomenon? [4]', Gastroenterology, 110, pp. 1325 - 1326, http://dx.doi.org/10.1053/gast.1996.v110.agast961325
,1996, 'Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer', Gastroenterology, 110, pp. 717 - 724, http://dx.doi.org/10.1053/gast.1996.v110.pm8608880
,1996, 'The Glasgow Dyspepsia Severity Score - A tool for the global measurement of dyspepsia', European Journal of Gastroenterology and Hepatology, 8, pp. 967 - 971, http://dx.doi.org/10.1097/00042737-199610000-00006
,1995, 'A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients', Gut, 36, pp. 534 - 538, http://dx.doi.org/10.1136/gut.36.4.534
,1995, 'Gastrin releasing peptide and its value in assessing gastric secretory function', Alimentary Pharmacology & Therapeutics, 9, pp. 341 - 347, http://dx.doi.org/10.1111/j.1365-2036.1995.tb00392.x
,1995, 'Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease', Gastroenterology, 109, pp. 681 - 691, http://dx.doi.org/10.1016/0016-5085(95)90374-7
,1995, 'Reply', Gastroenterology, 108, pp. 619, http://dx.doi.org/10.1016/0016-5085(95)90114-0
,